Back

Estimates of Cross-Border Menthol Cigarette Sales Following the Comprehensive Tobacco Flavor Ban in Massachusetts

Rich, J. J.

2022-04-27 health policy
10.1101/2022.04.24.22274236 medRxiv
Show abstract

On June 1, 2020, Massachusetts became the first state in the US to ban all flavored tobacco product sales, including menthol cigarettes. Recent research has estimated the reduction in cigarette sales in Massachusetts following the comprehensive tobacco flavor ban, but noted that missing data on border states was a major limitation of the findings. This letter replicates the procedures of Asare et al. with 1540 state-months and then adds Asare et al.s missing states with 2420 total observations for the period January 2017 to July 2021. The replication confirms Asare et al.s adjusted estimate for the reduction in menthol cigarettes, which falls within their 95% confidence interval. However, assigning Massachusetts and its bordering states as a single treatment group leads to an increase of 191.95 (95% CI, 96.82 to 287.09) total cigarette packs sold per 1000 people in the six-state region. In the 12-month period following the comprehensive flavor ban in Massachusetts, the state sold 29.96 million fewer cigarette packs compared to the prior period. However, a total of 33.36 million additional cigarette packs were sold during the same post-ban period in the counties that bordered Massachusetts. Given decreasing rates of smoking in all five bordering states between 2019 and 2020, the increase in border-state cigarette sales following the comprehensive flavor ban should be interpreted as a lower-bound estimate for cigarettes that were ultimately consumed in Massachusetts.

Matching journals

The top 5 journals account for 50% of the predicted probability mass.

1
JAMA Network Open
127 papers in training set
Top 0.1%
23.4%
2
Nicotine and Tobacco Research
13 papers in training set
Top 0.1%
10.5%
3
American Journal of Preventive Medicine
11 papers in training set
Top 0.1%
8.7%
4
Nicotine & Tobacco Research
11 papers in training set
Top 0.1%
6.6%
5
Addiction
25 papers in training set
Top 0.1%
5.0%
50% of probability mass above
6
PLOS ONE
4510 papers in training set
Top 33%
4.5%
7
International Journal of Drug Policy
11 papers in training set
Top 0.1%
4.3%
8
Nature Human Behaviour
85 papers in training set
Top 0.8%
3.7%
9
Clinical Microbiology and Infection
60 papers in training set
Top 0.2%
3.7%
10
JMIR Public Health and Surveillance
45 papers in training set
Top 0.8%
2.8%
11
Scientific Reports
3102 papers in training set
Top 43%
2.8%
12
Clinical Infectious Diseases
231 papers in training set
Top 3%
1.5%
13
eLife
5422 papers in training set
Top 46%
1.4%
14
FACETS
11 papers in training set
Top 0.2%
1.3%
15
JAMA
17 papers in training set
Top 0.2%
0.9%
16
BMJ Open
554 papers in training set
Top 11%
0.9%
17
PLOS Global Public Health
293 papers in training set
Top 5%
0.8%
18
Medical Decision Making
10 papers in training set
Top 0.2%
0.8%
19
Thorax
32 papers in training set
Top 0.7%
0.8%
20
BMC Public Health
147 papers in training set
Top 6%
0.7%
21
Cureus
67 papers in training set
Top 5%
0.7%
22
International Journal of Infectious Diseases
126 papers in training set
Top 4%
0.7%
23
BMC Medicine
163 papers in training set
Top 8%
0.5%
24
International Journal of Behavioral Nutrition and Physical Activity
15 papers in training set
Top 0.6%
0.5%
25
Nature Medicine
117 papers in training set
Top 6%
0.5%
26
PNAS Nexus
147 papers in training set
Top 3%
0.5%
27
Science of The Total Environment
179 papers in training set
Top 6%
0.5%